Table 1

Biometric data, electrophysiological neuropathy types, CMT Neuropathy Score and gene mutations

PMP22 duplication
(n=20)
MPZ mutation
(n=3)
EFL mutation
(n=4)
EGR2 mutation
(n=1)
ARHGEF10 mutation
(n=1)
Controls
(n=30)
Age, mean (range)47.6 (21–78)39.7 (10–69)47.3 (27–68)496742.7 (24–84)
Gender (M/F)10/102/12/20/11/019/11
Height (cm), mean (SD)161.9 (10.0)152.7 (16.1)168.4 (5.1)160.0 (NA)173.5 (NA)162.8 (11.5)
Weight (kg), mean (SD)58.2 (11.1)55.6 (17.5)63.5 (22.2)56.0 (NA)76.0 (NA)58.4 (10.8)
Body mass index, mean(SD)22.1 (3.3)23.4 (2.5)22.3 (7.6)23.8 (NA)25.2 (NA)21.9 (2.2)
Demyelinating type/axonal type20/02/12/21/00/1NA
CMT Neuropathy Score, mean (range)14.0 (7–28)12.0 (10–14)15.5 (9–25)7.07.0NA
Gene mutationsPMP22 duplicationCMT1B:
Tyr68Cys
(n=2);
CMT2J:
Thr124Met
CMT1F:
Pro8Leu
(n=2)
CMT2E:
Glu396Lys;
Tyr389Cys
Thr387AsnThr109IleNA
  • CMT, Charcot-Marie-Tooth disease; F, female; M, male; NA, not applicable.